July 26, 2021

sicklecellatient
Hematology
Sickle Cell Disease

Risk Factors ID'd for Severe COVID-19 With Sickle Cell Disease

Hydroxyurea use does not impact development of serious COVID-19 or need for hospitalization in children or adults A history of severe pain episodes and coexisting organ conditions may increase the risk for severe COVID-19 illness and hospitalization in individuals living with sickle cell disease (SCD), according to a study published online July 1 in Blood...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.